Displaying 1 - 18 of 150
Scientists at Swinburne University of Technology and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) are working together to improve the experimental design of research into 5G and future high-frequency wireless technologies.
ARPANSA’s Australian Clinical Dosimetry Service (ACDS) has carried out its first live stereotactic radiosurgery (SRS) audit which supports dose accuracy in radiation therapy used to treat brain cancer.
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) is pleased to announce the launch of their new website.
Addressing human and organisational factors that impact nuclear safety is among the changes to the 2018 Australian Radiation Protection and Nuclear Safety (ARPANSA) Regulations that came into effect on 10 August 2022.
Scientists from the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) will be countering misinformation about radio waves as part of National Science Week at a free event at the Science Gallery, University of Melbourne on 17 August 2022.
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) and ANSTO have coordinated with the IAEA to donate radiation measurement and personal protective equipment to Ukraine.
Exposing humans to ultraviolet radiation to test sunscreen effectiveness should be phased out, according to scientists and cancer experts.
Calculating exposure from naturally occurring radioactive material (NORM) has been standardised by the Australian Radiation Protection and Nuclear Safety Agency to encourage national uniformity and ongoing alignment with international best practice.
ARPANSA has teamed up with Cancer Council Victoria and the Australian Bureau of Meteorology to create a SunSmart Global UV app.
ARPANSA has released an advisory note on the public health considerations for disposal of radioactive waste.
ARPANSA is working with the International Atomic Energy Agency (IAEA) and dosimetry auditors globally to develop a world first film dosimetry intercomparison tool.
Illegal laser pointers that are being imported into the country due to incorrect product labelling is an issue being pinpointed to Australia’s Freight and Trade Alliance this month by ARPANSA scientist Dr Chris Brzozek.
Recruitment is currently underway for the next Chief Radiation Health Scientist and Head of Radiation Health Services Branch of ARPANSA.
ARPANSA has provided funding to RMIT to investigate the impact of non-ionising radiation on cell permeability. This research is funded as the first ‘major project’ under ARPANSA’s new EME Program Research Framework.
ARPANSA experts have published an article in Public Health Research and Practice, a journal of the Sax Institute, that calls for more research into the use of non-ionising radiation for cosmetic purposes.
The Australian Government announces the appointment of Dr Gillian Hirth as Chief Executive Officer (CEO) of ARPANSA following the retirement of current CEO, Dr Carl-Magnus Larsson.
ARPANSA has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to prepare a site for the Intermediate Level Waste Capacity Increase (ILWCI) facility.
